Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ALR Stock Summary
In the News
Healthcare REITs: Life After The Pandemic
For Healthcare REITs - the physical epicenter of the pandemic - the road to recovery has remained inconsistent across its distinct sub-sectors, with "private-pay" segments now showing notable improvement while "public-pay" segments relapse. Public-pay segments - Hospital and Skilled-Nursing - have seen a re-intensification of tenant operator issues amid pressure from soaring labor costs and waning government fiscal support, triggering some missed rents and lease renegotiations.
Warm Winter For Global Economy
U.S. equity markets rebounded following their worst week of the year as investors parsed data showing surprising resilience in global economic activity this winter despite stiff interest rate headwinds. Snapping a three-week skid and notching its best week since late January, the S&P 500 advanced 2.0% this week, while the tech-heavy Nasdaq 100 rallied nearly 3%.
Why Is AlerisLife (ALR) Stock Up 58% Today?
AlerisLife (NASDAQ: ALR ) stock is taking off on Friday following news of a $43.8 million deal with ABP Acquisition LLC. That deal has ABP Acquisition LLC agreeing to acquire AlerisLife for $1.31 per share in cash.
AlerisLife Inc. (ALR) Q3 2022 Earnings Call Transcript
AlerisLife Inc. (NASDAQ:ALR ) Q3 2022 Earnings Conference Call November 3, 2022 1:00 PM ET Company Participants Michael Kodesch - Director of IR Jeffrey Leer - President, CEO, CFO and Treasurer Heather Pereira - Chief Financial Officer and Treasurer Conference Call Participants Andrew Seader - B. Riley Financials Operator Good day, and welcome to the AlerisLife Inc. Third Quarter 2022 Conference Call.
AlerisLife Inc. (ALR) CEO Jeff Leer on Q2 2022 Results - Earnings Call Transcript
AlerisLife Inc. (NASDAQ:ALR ) Q2 2022 Earnings Conference Call August 4, 2022 1:00 PM ET Company Participants Michael Kodesch - Director of IR Jeff Leer - President, CEO, CFO and Treasurer Conference Call Participants Operator Good day, and welcome to the AlerisLife Second Quarter 2022 Earnings Call. [Operator Instructions] Please note, this event is being recorded.
AlerisLife (ALR) Reports Q2 Loss, Misses Revenue Estimates
Five Star (ALR) delivered earnings and revenue surprises of -33.33% and 4.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
AlerisLife Inc. Second Quarter 2022 Conference Call Scheduled for Thursday, August 4th
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that it will issue a press release containing its second quarter 2022 financial results after the Nasdaq closes on Wednesday, August 3, 2022. On Thursday, August 4, 2022 at 1:00 p.m. Eastern Time, President and Chief Executive Officer, Chief Financial Officer and Treasurer Jeff Leer will host a conference call to discuss these results. The conference call telephone number is (877) 329-4332. Participants calling from o
AlerisLife Inc. (ALR) CEO on Q1 2022 Results - Earnings Call Transcript
AlerisLife Inc. (NASDAQ:ALR ) Q1 2022 Earnings Conference Call May 4, 2022 1:00 PM ET Company Participants Michael Kodesch - Director of Investor Relations Jeff Leer - Interim President and Chief Executive Officer and Chief Financial Officer Conference Call Participants Bryan Maher - B Riley, FBR Operator Good afternoon, and welcome to the AlerisLife First Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
AlerisLife Inc. First Quarter 2022 Conference Call Scheduled for Wednesday, May 4th
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that it will issue a press release containing its first quarter 2022 financial results after the Nasdaq closes on Tuesday, May 3, 2022. On Wednesday, May 4, 2022 at 1:00 p.m. Eastern Time, President and Chief Executive Officer Katie Potter and Executive Vice President, Chief Financial Officer and Treasurer Jeff Leer will host a conference call to discuss these results. The conference call telephone number is (877) 329
Alerislife, Inc. (ALR) CEO Katherine Potter on Q4 2021 Results - Earnings Call Transcript
Alerislife, Inc. (ALR) CEO Katherine Potter on Q4 2021 Results - Earnings Call Transcript
ALR Financial details
ALR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 283.74 | 279.83 | 282.69 | 36.98 | 29.58 | |
Net income per share | -4.25 | -14.91 | -4.11 | -0.24 | -0.94 | |
Operating cash flow per share | 3.48 | -10.91 | -0.82 | 1.63 | -0.24 | |
Free cash flow per share | -10.97 | -20.77 | -12.31 | 1.46 | -0.54 | |
Cash per share | 9.91 | 10 | 10.55 | 3.31 | 2.5 | |
Book value per share | 29.47 | 14.32 | 23.97 | 6.69 | 5.75 | |
Tangible book value per share | 29.41 | 14.29 | 23.93 | 6.69 | 5.75 | |
Share holders equity per share | 29.47 | 14.32 | 23.97 | 6.69 | 5.75 | |
Interest debt per share | 2.54 | 12.55 | 6.53 | 1.06 | 0.71 | |
Market cap | 2.51B | 2.53B | 14.37M | 90.32M | 90.67M | |
Enterprise value | 2.49B | 2.56B | 12.7M | 37.54M | 44.45M | |
P/E ratio | -120.03 | -34.2 | -0.7 | -11.9 | -3.05 | |
Price to sales ratio | 1.8 | 1.82 | 0.01 | 0.08 | 0.1 | |
POCF ratio | 146.56 | -46.72 | -3.5 | 1.76 | -11.97 | |
PFCF ratio | -46.48 | -24.55 | -0.23 | 1.97 | -5.33 | |
P/B Ratio | 17.3 | 35.6 | 0.12 | 0.43 | 0.5 | |
PTB ratio | 17.3 | 35.6 | 0.12 | 0.43 | 0.5 | |
EV to sales | 1.78 | 1.84 | 0.01 | 0.03 | 0.05 | |
Enterprise value over EBITDA | 145.99 | -73.49 | 6.8 | 1.36 | 7.98 | |
EV to operating cash flow | 145.5 | -47.27 | -3.09 | 0.73 | -5.87 | |
EV to free cash flow | -46.15 | -24.84 | -0.21 | 0.82 | -2.61 | |
Earnings yield | -0.01 | -0.03 | -1.43 | -0.08 | -0.33 | |
Free cash flow yield | -0.02 | -0.04 | -4.29 | 0.51 | -0.19 | |
Debt to equity | 0.06 | 0.83 | 0.25 | 0.15 | 0.11 | |
Debt to assets | 0.02 | 0.15 | 0.09 | 0.07 | 0.06 | |
Net debt to EBITDA | -1.06 | -0.86 | -0.89 | -1.91 | -8.3 | |
Current ratio | 0.9 | 0.6 | 0.87 | 1.47 | 1.33 | |
Interest coverage | -5.35 | -23.71 | -5.65 | 9.77 | -3.75 | |
Income quality | -0.82 | 0.73 | 0.21 | -6.77 | 0.25 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.2 | 0.21 | 0.16 | 0.08 | 0.09 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -4.15 | 0.9 | 13.99 | -0.11 | 1.25 | |
Capex to revenue | -0.05 | -0.04 | -0.04 | 0 | -0.01 | |
Capex to depreciation | -1.86 | -1.36 | -3.46 | -0.49 | -0.79 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 53.07 | 69.32 | 47.07 | 6.02 | 11.04 | |
ROIC | -0.12 | -0.55 | -0.09 | 0.07 | -0.03 | |
Return on tangible assets | -0.04 | -0.18 | -0.06 | -0.02 | -0.08 | |
Graham Net | -50.72 | -50.43 | -24.88 | -3.76 | -3.3 | |
Working capital | -21.46M | -91.64M | -20.93M | 84.4M | 45.93M | |
Tangible asset value | 144.72M | 70.98M | 119.79M | 210.53M | 181.59M | |
Net current asset value | -133.73M | -196.4M | -82.44M | 18.63M | -7.85M | |
Invested capital | 0.06 | 0.83 | 0.25 | 0.15 | 0.11 | |
Average receivables | 49.39M | 44.53M | 42.67M | 72.59M | 78.18M | |
Average payables | 71.59M | 72.2M | 76.06M | 52.95M | 30.49M | |
Average inventory | 0 | 0 | 18.68M | -39.48M | -84.95M | |
Days sales outstanding | 11.36 | 11.97 | 10.25 | 33.08 | 19.88 | |
Days payables outstanding | 24.7 | 22.2 | 25.39 | 8.17 | 16.08 | |
Days of inventory on hand | 0 | 0 | 11.5 | -40.51 | -22.97 | |
Receivables turnover | 32.13 | 30.48 | 35.63 | 11.03 | 18.36 | |
Payables turnover | 14.78 | 16.44 | 14.38 | 44.68 | 22.7 | |
Inventory turnover | 0 | 0 | 31.73 | -9.01 | -15.89 | |
ROE | -0.14 | -1.04 | -0.17 | -0.04 | -0.16 | |
Capex per share | -14.45 | -9.86 | -11.49 | -0.17 | -0.3 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.14 | 5.72 | 5.45 | 5.38 | 5.73 | |
Net income per share | -0.32 | -0.33 | -0.31 | -0.28 | -0.27 | |
Operating cash flow per share | -0.51 | -0.3 | -1.04 | -0.18 | -0.18 | |
Free cash flow per share | -0.6 | -0.36 | -1.24 | -0.27 | -0.31 | |
Cash per share | 3.15 | 2.49 | 3.11 | 2.92 | 2.6 | |
Book value per share | 6.07 | 5.74 | 5.4 | 5.12 | 4.84 | |
Tangible book value per share | 6.07 | 5.74 | 5.4 | 5.12 | 4.84 | |
Share holders equity per share | 6.07 | 5.74 | 5.4 | 5.12 | 4.84 | |
Interest debt per share | 0.68 | 0.67 | 2.47 | 2.48 | 2.47 | |
Market cap | 90.74M | 90.87M | 68.34M | 38.17M | 30.28M | |
Enterprise value | 31.54M | 44.65M | 57.86M | 32.49M | 28.28M | |
P/E ratio | -2.22 | -2.15 | -1.76 | -1.08 | -0.89 | |
Price to sales ratio | 0.4 | 0.5 | 0.39 | 0.22 | 0.17 | |
POCF ratio | -5.64 | -9.69 | -2.07 | -6.69 | -5.16 | |
PFCF ratio | -4.79 | -7.93 | -1.73 | -4.52 | -3.05 | |
P/B Ratio | 0.47 | 0.5 | 0.4 | 0.23 | 0.2 | |
PTB ratio | 0.47 | 0.5 | 0.4 | 0.23 | 0.2 | |
EV to sales | 0.14 | 0.25 | 0.33 | 0.19 | 0.15 | |
Enterprise value over EBITDA | -4.59 | -6.01 | -11.43 | -12.03 | -11.69 | |
EV to operating cash flow | -1.96 | -4.76 | -1.75 | -5.69 | -4.82 | |
EV to free cash flow | -1.66 | -3.9 | -1.47 | -3.84 | -2.85 | |
Earnings yield | -0.11 | -0.12 | -0.14 | -0.23 | -0.28 | |
Free cash flow yield | -0.21 | -0.13 | -0.58 | -0.22 | -0.33 | |
Debt to equity | 0.11 | 0.11 | 0.45 | 0.48 | 0.5 | |
Debt to assets | 0.06 | 0.06 | 0.2 | 0.2 | 0.2 | |
Net debt to EBITDA | 8.61 | 6.22 | 2.07 | 2.11 | 0.82 | |
Current ratio | 1.51 | 1.33 | 1.84 | 1.69 | 1.58 | |
Interest coverage | -13.19 | -34.19 | -8.05 | -4.89 | -3.89 | |
Income quality | 1.58 | 0.87 | 3.4 | 0.65 | 0.69 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0.01 | |
Payout ratio | -0.01 | 0 | 0 | -0.01 | -0.03 | |
Sales general and administrative to revenue | 0.1 | 0.1 | 0.11 | 0.1 | 0.09 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.18 | 0.22 | 0.19 | 0.48 | 0.69 | |
Capex to revenue | -0.01 | -0.01 | -0.04 | -0.02 | -0.02 | |
Capex to depreciation | -0.97 | -0.71 | -2.02 | -0.84 | -1.31 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.64 | 6.56 | 6.1 | 5.65 | 5.39 | |
ROIC | -0.03 | -0.05 | -0.03 | -0.02 | -0.02 | |
Return on tangible assets | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 | |
Graham Net | -1.51 | -2.45 | -2.6 | -2.82 | -3 | |
Working capital | 62.78M | 45.93M | 96.77M | 83.75M | 73.19M | |
Tangible asset value | 191.77M | 181.59M | 171.54M | 163.01M | 154.33M | |
Net current asset value | 6.48M | -7.85M | -13.3M | -21.89M | -28.89M | |
Invested capital | 0.11 | 0.11 | 0.45 | 0.48 | 0.5 | |
Average receivables | 65.63M | 46.39M | 54.52M | 58.66M | 62.68M | |
Average payables | 19.14M | 26.98M | 24.69M | 13.42M | 15.67M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 16.68 | 25.31 | 30.22 | 31.13 | 32.6 | |
Days payables outstanding | 7.17 | 20.16 | 6.67 | 8.63 | 8.75 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 5.39 | 3.56 | 2.98 | 2.89 | 2.76 | |
Payables turnover | 12.56 | 4.47 | 13.49 | 10.43 | 10.28 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.05 | -0.06 | -0.06 | -0.05 | -0.06 | |
Capex per share | -0.09 | -0.07 | -0.2 | -0.09 | -0.13 |
ALR Frequently Asked Questions
What is AlerisLife Inc. stock symbol ?
AlerisLife Inc. is a US stock , located in Newton of Ma and trading under the symbol ALR
What is AlerisLife Inc. stock quote today ?
AlerisLife Inc. stock price is $- today.
Is AlerisLife Inc. stock public?
Yes, AlerisLife Inc. is a publicly traded company.